In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges...
Product
Philips xcelera vulnerabilities
3 published CVES affecting Philips xcelera, from public sources (CVE.org, NVD, CISA KEV, FIRST EPSS, OSV).
- Total
- 3
- Critical
- 0
- High
- 2
- Medium
- 1
- Low
- 0
- Unscored
- 0
- CISA KEV
- 0
Latest Philips xcelera CVEs
Newest publication first
-
MediumCVSS 6.7 EPSS 0.45%
-
HighCVSS 7.8 EPSS 0.39%
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbi...
-
HighCVSS 7.2 EPSS 2.2%
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements...
Sources: CVE.org, NVD, CISA KEV, FIRST EPSS, OSV and public exploit-reference metadata. Product matching comes from the published CVE records. A proof-of-concept means public code exists; it is not evidence of exploitation.